LIVE · EDGAR13F x Form 4Sandbox publicOpen research surface

13FLOW

A source-linked SEC-filings trust layer for agent builders and research operations teams that need 13F ownership, bounded Form 4 context, quality warnings and API/MCP contracts before a workflow cites the data.

45tracked funds
1217SEC filings
0.0%value coverage
2026-06-30latest 13F quarter
Open research appOpen SignalsTry sandboxTrust artifact
Live data status: LIVE EDGAR.uses_synthetic_data=false · data_as_of=2026-07-06
/api/funds serves 45 fundsfilings=1217; latest_rows=1156
latest 13F quarter 2026-06-30SHA d002a2dd2ffc
10 quality warnings0 unit-scale candidates
Professional workflow

Built for builders who need evidence first

13FLOW should feel like a compact trust layer: instant sandbox, visible limitations and source-linked evidence before any workflow relies on it.

01 · Triage

Signal cockpit

Prioritize names where 13F pressure and Form 4 activity overlap, then drill into source evidence.

02 · Validate

Fund and issuer context

Check who moved, what changed, reported values, accessions and quality flags before a model update.

03 · Integrate

API and agent surfaces

Use read-only endpoints, OpenAPI, sandbox probes and the minimal MCP boundary for downstream workflows.

Agent buildersSource-linked filing context agents can cite without losing the boundary.
Research opsRead-only contracts, status endpoints and workflow-ready evidence.
ComplianceMethodology, limitations and legal terms are visible before access.
Open boundaryPublic pages stay read-only and source-linked; admin surfaces remain private.

What is live

  • Read-only public 13F data from SEC EDGAR-derived local storage.
  • Trust-layer artifact broader than the legacy 25-ticker validation sample when live holdings allow.
  • Public API, MCP public tools, methodology contracts and status pages.

Funds Stocks Signals OpenAPI

What is not claimed

  • No validated alpha claim.
  • No probability or expected-return model.
  • No complete view of shorts, non-US books, full derivatives or intra-quarter fund trading.
  • No exhaustive insider-only or distribution universe yet.
  • No investment advice or performance promise.
  • No standalone MCP product claim.
  • No private entitlement or SLA from public pages.
  • No SLA or redistribution right without written agreement.

mechanical_evidence_ready_for_review_metrics_unreviewed rows=125; tickers=25; row_errors=0

Validation evidence Methodology Status FAQ